Emerging Med - Secondary
 SEARCH BY PHONE
1.877.601.8601
8:30 AM - 6:00 PM EST (M-F)
Find trials
that match your profile.
 




 




 
This website is certified by Health On the Net Foundation. Click to verify.
 
 


Please click on a letter to view an alphabetical listing of terms, or type a word (or partial word) in the "Word Search" box. Your search results will appear below.

                              A  B  C  D  E  F  G  H  I  J  K  L  M  N  O  P  Q  R  S  T  U  V  W  X  Y  Z

Word Search  



   
 Displaying Page 1 of 6       

  term   description
  K-RAS GENE   A gene that may cause cancer when it is mutated (changed). The K-ras gene makes the KRAS protein, which is involved in cell signaling pathways, cell growth, and apoptosis (cell death). Agents that block the activity of the mutated K-ras gene or its protein may stop the growth of cancer. Also called Kras gene.
  KAHLER DISEASE   A type of cancer that begins in plasma cells (white blood cells that produce antibodies). Also called multiple myeloma, myelomatosis, and plasma cell myeloma.
  KALETRA   A combination of the drugs ritonavir and lopinavir. It is used to treat infection with HIV (the virus that causes AIDS). It is also being studied in the treatment of some types of cancer. Kaletra blocks the ability of HIV to make copies of itself and may help other anticancer drugs work better or may block the growth of cancer cells. Ritonavir blocks the breakdown of lopinavir. Kaletra is a type of anti-HIV agent and a type of protease inhibitor. Also called lopinavir/ritonavir.
  KAPOSI SARCOMA   A type of cancer characterized by the abnormal growth of blood vessels that develop into skin lesions or occur internally.
  KAPOSI SARCOMA-ASSOCIATED HERPESVIRUS   A type of herpesvirus that may cause Kaposi sarcoma (a rare cancer that can cause skin lesions) and a type of lymphoma (cancer that begins in the lymph system), especially in patients who have a weak immune system. Also called HHV8, human herpesvirus 8, and KSHV.
  KAPOSI''S SARCOMA   A type of cancer characterized by the abnormal growth of blood vessels that develop into skin lesions or occur internally.
  KAPOSI'S SARCOMA   A type of cancer characterized by the abnormal growth of blood vessels that develop into skin lesions or occur internally.
  KAPOSI'S SARCOMA-ASSOCIATED HERPESVIRUS   KSHV. A type of herpesvirus that may cause Kaposi''s sarcoma (a rare cancer that can cause skin lesions) and a type of lymphoma (cancer that begins in the lymph system), especially in patients who have a weak immune system. Also called KSHV, human herpesvirus 8, and HHV8.
  KARENITECIN   A drug being studied in the treatment of cancer. It belongs to a family of drugs called topoisomerase inhibitors. It is related to the anticancer drug camptothecin.
  KARNOFSKY PERFORMANCE STATUS   KPS. A standard way of measuring the ability of cancer patients to perform ordinary tasks. The Karnofsky Performance scores range from 0 to 100. A higher score means the patient is better able to carry out daily activities. KPS may be used to determine a patient's prognosis, to measure changes in a patient's ability to function, or to decide if a patient could be included in a clinical trial.

 
© 2014 EmergingMed Home  |  Contact Us  |  How Matching Works  |  Privacy Policy  |  Terms & Conditions
 
-->